NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

I agree with a lot of your thought processes here, but have a few disagreements.

The fact that they have a big booth is a clear sign that they HOPE they will have TLD/journal done in time for ASCO.

This is definitely a possibility. And I think it is true, the booth represents the hope that they'll have publication before ASCO. However, it is not a 'clear sign' of this. Call it FUD, but I don't think you can logically eliminate the possibility that NWBO knows they likely won't have results published before ASCO, but reserved a large booth because they also know the investor base is diligent and would take NWBO not participating in ASCO as a sure sign that results are not coming soon. So the booth could just be to keep the short term smoke screen up and prevent a sell off.

Again, and I stress cause I know I'll get bashed as a FUDster for this, I don't think the latter case is the answer. But I also don't discount that it is a possibility. So I can't say the booth is 'a clear sign that they hope they'll have TLD prior to ASCO', because there are other things it could mean.

They have clearly expressed, on every occasion they have had, that TLD will be followed by a journal article and will not be presented in a conference.

This isn't true. They have only said that they won't plan the release around a conference. They have said that if a large conference happens to line up nicely with the timing of the release, that they would possibly use it as a venue as they did with the 2018 blinded results. So, while the journal would need to be released prior to the conference reveal, it does not eliminate the possibility that the results will be presented at a conference.